Shiran Shapira, n/a

Integrated Cancer Prevention Center, Tel Aviv Medical Center, Tel Aviv 6423906, Israel, Israel

Disclosure(s): No financial relationships to disclose

Poster(s):

• 1153 - Safety and Potential Efficacy of Exosomes Overexpressing CD24 (EXO-CD24) for the Prevention of Clinical Deterioration in Patients with Moderate or Severe COVID-19: A Phase II, Randomized, Single-blinded Study.
  Friday, October 21, 2022

  12:15 PM – 1:30 PM US ET